Biosafety Testing Services

Sartorius Stedim BioOutsource is a leading provider of cGMP and GLP biosafety testing services for biopharmaceutical drugs and vaccines with a strong customer focus. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.

As a leading and experienced provider of biologics safety testing, we offer a comprehensive range of off-the-shelf assays to ensure cell banks, virus banks, raw materials of animal origin, bulk harvest and clinical batches are free of bacteria, fungi, yeasts, mycoplasma, adventitious viruses and any other potential contaminants. All our assays are performed in our cGMP biosafety labs.

BioOutsource provides biologics safety testing of the following materials produced during the drug development process:

Our range of biosafety assays ensures your product is safe and free from potential contaminants:

We offer a unique customer focused approach to help advance our clients life changing drug candidates from preclinical development through to commercialization. Learn more about our unique approach here.

Contact our experts to discuss your biosafety testing requirements.

Contact our experts

 

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.